{"title":"鉴别慢性鼻窦炎的内源性:巨噬细胞的新作用。","authors":"Zhibo Wang, Zhichen Liu, Ming Wang, Luo Zhang","doi":"10.1080/1744666X.2026.2747885","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder characterized by different endotypes classically known as type 1/2/3 inflammation. Macrophages play a pivotal role in the pathogenesis of CRS. Under diverse inflammatory conditions, macrophages can polarize into different subsets and exert distinct functions across CRS endotypes. Recently, single-cell transcriptome analysis identified a series of macrophage subsets that have specific gene expression signatures associated with CRS endotypes.</p><p><strong>Areas covered: </strong>A literature search was conducted using PubMed with keywords 'CRS,' 'endotype,' and 'macrophage' and related terms, focusing on studies published over the past 10 years. This review dissects macrophage heterogeneity across CRS endotypes, summarizes how diverse stimulus factors shape macrophage states, and updates their roles under endotypes, providing clues for the development of macrophage-based biomarkers for endotyping and targeted therapy.</p><p><strong>Expert opinion: </strong>Effectively distinguishing CRS endotypes is meaningful for personalized therapies. An endotype-based interpretation of macrophage heterogeneity helps explain the divergent patterns of inflammation in CRS. In addition, the nasal tissue-resident macrophages attract growing interest as their contribution to olfactory loss in CRS.</p>","PeriodicalId":12175,"journal":{"name":"Expert Review of Clinical Immunology","volume":" ","pages":"1-11"},"PeriodicalIF":4.0000,"publicationDate":"2026-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Distinguishing the endotypes of Chronic rhinosinusitis: the emerging roles of macrophages.\",\"authors\":\"Zhibo Wang, Zhichen Liu, Ming Wang, Luo Zhang\",\"doi\":\"10.1080/1744666X.2026.2747885\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder characterized by different endotypes classically known as type 1/2/3 inflammation. Macrophages play a pivotal role in the pathogenesis of CRS. Under diverse inflammatory conditions, macrophages can polarize into different subsets and exert distinct functions across CRS endotypes. Recently, single-cell transcriptome analysis identified a series of macrophage subsets that have specific gene expression signatures associated with CRS endotypes.</p><p><strong>Areas covered: </strong>A literature search was conducted using PubMed with keywords 'CRS,' 'endotype,' and 'macrophage' and related terms, focusing on studies published over the past 10 years. This review dissects macrophage heterogeneity across CRS endotypes, summarizes how diverse stimulus factors shape macrophage states, and updates their roles under endotypes, providing clues for the development of macrophage-based biomarkers for endotyping and targeted therapy.</p><p><strong>Expert opinion: </strong>Effectively distinguishing CRS endotypes is meaningful for personalized therapies. An endotype-based interpretation of macrophage heterogeneity helps explain the divergent patterns of inflammation in CRS. In addition, the nasal tissue-resident macrophages attract growing interest as their contribution to olfactory loss in CRS.</p>\",\"PeriodicalId\":12175,\"journal\":{\"name\":\"Expert Review of Clinical Immunology\",\"volume\":\" \",\"pages\":\"1-11\"},\"PeriodicalIF\":4.0000,\"publicationDate\":\"2026-10-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Expert Review of Clinical Immunology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/1744666X.2026.2747885\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"IMMUNOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Clinical Immunology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/1744666X.2026.2747885","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
Distinguishing the endotypes of Chronic rhinosinusitis: the emerging roles of macrophages.
Introduction: Chronic rhinosinusitis (CRS) is a heterogeneous inflammatory disorder characterized by different endotypes classically known as type 1/2/3 inflammation. Macrophages play a pivotal role in the pathogenesis of CRS. Under diverse inflammatory conditions, macrophages can polarize into different subsets and exert distinct functions across CRS endotypes. Recently, single-cell transcriptome analysis identified a series of macrophage subsets that have specific gene expression signatures associated with CRS endotypes.
Areas covered: A literature search was conducted using PubMed with keywords 'CRS,' 'endotype,' and 'macrophage' and related terms, focusing on studies published over the past 10 years. This review dissects macrophage heterogeneity across CRS endotypes, summarizes how diverse stimulus factors shape macrophage states, and updates their roles under endotypes, providing clues for the development of macrophage-based biomarkers for endotyping and targeted therapy.
Expert opinion: Effectively distinguishing CRS endotypes is meaningful for personalized therapies. An endotype-based interpretation of macrophage heterogeneity helps explain the divergent patterns of inflammation in CRS. In addition, the nasal tissue-resident macrophages attract growing interest as their contribution to olfactory loss in CRS.
期刊介绍:
Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology.
Articles focus on the following key areas:
• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines
• Performance and benefits of newly approved therapeutic agents
• New diagnostic approaches
• Screening and patient stratification
• Pharmacoeconomic studies
• New therapeutic indications for existing therapies
• Adverse effects, occurrence and reduction
• Prospects for medicines in late-stage trials approaching regulatory approval
• Novel treatment strategies
• Epidemiological studies
• Commentary and comparison of treatment guidelines
Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.